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Background: Streptococcus pneumoniae and Haemophilus influenzae cause pneumonia and as Neisseria meningitidis
they are important agents of meningitis. Although several PCR methods have been described for these bacteria
the specificity is an underestimated problem. Here we present a quantitative multiplex real-time PCR (qmPCR) for
detection of S. pneumoniae (9802 gene fragment), H. influenzae (omp P6 gene) and N. meningitidis (ctrA gene). The
method was evaluated on bronchoalveolar lavage (BAL) samples from 156 adults with lower respiratory tract
infection (LRTI) and 31 controls, and on 87 cerebrospinal fluid (CSF) samples from meningitis patients.
Results: The analytical sensitivity was not affected by using a combined mixture of reagents and a combined DNA
standard (S. pneumoniae/H. influenzae/N. meningitidis) in single tubes. By blood- and BAL-culture and S. pneumoniae
urinary antigen test, S. pneumoniae and H. influenzae were aetiological agents in 21 and 31 of the LTRI patients,
respectively. These pathogens were identified by qmPCR in 52 and 72 of the cases, respectively, yielding
sensitivities and specificities of 95% and 75% for S. pneumoniae, and 90% and 65% for H. influenzae, respectively.
When using a cut-off of 10
5 genome copies/mL for clinical positivity the sensitivities and specificities were 90%
and 80% for S. pneumoniae, and 81% and 85% for H. influenzae, respectively. Of 44 culture negative but qmPCR
positive for H. influenzae, 41 were confirmed by fucK PCR as H. influenzae. Of the 103 patients who had taken
antibiotics prior to sampling, S. pneumoniae and H. influenzae were identified by culture in 6% and 20% of the
cases, respectively, and by the qmPCR in 36% and 53% of the cases, respectively.
In 87 CSF samples S. pneumoniae and N. meningitidis were identified by culture and/or 16 S rRNA in 14 and 10
samples and by qmPCR in 14 and 10 samples, respectively, giving a sensitivity of 100% and a specificity of 100%
for both bacteria.
Conclusions: The PCR provides increased sensitivity and the multiplex format facilitates diagnosis of
S. pneumoniae, H. influenzae and N. meningitidis and the assay enable detection after antibiotic treatment has been
installed. Quantification increases the specificity of the etiology for pneumonia.
Background
Streptococcus pneumoniae and Haemophilus influenzae
are major causes of community-acquired pneumonia
(CAP) [1,2] and as Neisseria meningitidis they are
important agents of meningitis [3-5]. Identification of
the microbiological cause of CAP and meningitis is
important, as it enables pathogen-directed antibiotic
therapy. Conventional detection of bacteria is based on
culture and phenotypic characterization. However, cul-
ture methods are time-consuming and have relatively
low sensitivity, especially when antibiotics have been
given to the patient prior to sampling [6]. The use of
nucleic acid amplification tests, such as quantitative
real-time polymerase chain reaction (qPCR), have
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in respiratory secretions and cerebrospinal fluid (CSF).
Several qPCR assays for the detection of S. pneumoniae
[7-9], H. influenzae [10-12] and N. meningitidis [13] have
been developed and multiplex detection of several target
DNAs in a single tube is achievable [14-16]. Still, the spe-
cificity of methods used is an underestimated problem and
commonly used targets have been shown to be unspecific
and causing misleading results. An illustrative example is
the pneumolysin (ply) gene for the detection of S. pneumo-
niae [17-19]. For detection of H. influenzae, a species with
frequent exchange of genetic elements, the problem is
even worse and most target genes used are problematic.
The bexA is not present in all strains of H. influenzae [20],
while 16 S rRNA and rnpB do not provide specific detec-
tion [21]. We have recently developed qPCRs for specific
detection of S. pneumoniae, based on the Spn9802 frag-
ment [17], and for the detection of H. influenzae,b a s e do n
the outer membrane protein P6 [21]. Real time PCR assays
for detection of N. meningitidis have been based on genes
as porA [22] and ctrA [14,16].
Here we present a new quantitative multiplex PCR
(qmPCR) method for detection of S. pneumoniae, H.
influenzae and N. meningitidis.T h em e t h o dw a se v a l u -
ated on a collection of bronchoalveolar lavage (BAL)
and cerebrospinal fluid specimens for detection of lower
respiratory tract infection (LRTI) and meningitis due to
these three bacteria species.
Methods
Patients and controls
From 1997 through 2000, 159 consecutively identified
immunocompetent adult patients who were hospitalised
for LRTI at the Department of Internal Medicine, Silke-
borg County Hospital, Silkeborg, Denmark, were
enrolled in a prospective study [23]. The criteria for
LRTI were fever and/or an increased leukocyte count
(≥ 11 × 10
9 /L), together with increased focal symptoms
from the lower airways with at least one of three newly
developed symptoms of increased dyspnoea, increased
coughing and/or increased sputum purulence.
The enrolled patients underwent standardized fibre-
optic bronchoscopy within 24 hours from admission.
For the present study, BAL fluid was available in 156
patients, median age 63 years (range 26-90 years). A
chronic lung disease was documented in 72 patients
(46%), 31% were current and 40% were previous smo-
kers. New X-ray infiltrates were identified in 87 patients
(56%). Antibiotics had been taken within 7 days prior to
bronchoscopy in 103 cases (66%).
As controls, 31 adult patients, median age 64 years
(range 30-77 years), who consecutively underwent fibre-
optic bronchoscopy for suspected malignancy and who
did not have pulmonary infection were included.
Nineteen of them had lung malignancies and 12 had no
pathology identified by bronchoscopy or radiological
examinations. Twenty-seven controls (87%) were current
or previous smokers.
CSF samples sent for culture to the Bacteriological
Laboratory, Sahlgrenska University Hospital, Gothen-
burg, Sweden during a four year period were used in
the study. Specimens were eligible if the total CSF white
blood cell (WBC) count was ≥10 × 10
6 /L indicating
meningeal inflammation. Only one CSF sample from
each patient was included. Medical records of all
patients included in the study were reviewed retrospec-
tively for a final diagnosis, predisposing factors, treat-
ment and outcome by one doctor. All 87 specimens
were included in a study previously published for 16 S
rRNA gene PCR [24] and the relevance of the PCR find-
ings and bacterial cultures to the final diagnosis was
evaluated and compared with the clinical findings and
other laboratory results. The median age of the patients
were 34 years (range 1 day- 91 years).
Fibre-optic bronchoscope
In brief, the fibre-optic bronchoscope was introduced
through the nose or through the mouth. The tip of the
bronchoscope was wedged into the segment of bronchus
affected by a pulmonary infiltrate, or, if no infiltrate was
available, into the middle lobe. A sterile, thin tube was
then introduced into the working channel of the
bronchoscope, and lavage was then performed. One to
three portions of 60 mL of isotonic NaCl were used for
lavage, and the aspirated fluid was collected in one sin-
gle portion for microbiological analyses.
Conventional diagnostic methods
BAL fluid from the LRTI patients and the controls were
analysed with culture (but no Gram staining) at the
Department of Clinical Microbiology, Aarhus University
Hospital (Aalborg, Denmark), within a maximum of 6 h
from the time of sampling. The specimens were cultured
on 5% horse blood agar and chocolate agar with semi-
quantitative determinations by dispersion of 1 and 10
μL on each half of the plate. The plates were incubated
in 5% carbon dioxide at 35°C for 24-48 h.
From 152 LRTI patients, blood samples were collected
for culture with a Bactec blood-culturing system (BioMér-
ieux, Marcy-Etoile, France) at the Department of Clinical
Microbiology, Aarhus University Hospital. Non-frozen
urine samples collected from 142 LRTI patients were sent
to the Department of Bacteriology, Mycology and Parasi-
tology, Statens Serum Institute, Copenhagen, Denmark,
and were analyzed for pneumococcal capsular polysac-
charides by countercurrent immunoelectrophoresis [25].
CSF samples were submitted for routine bacterial cul-
ture and chemistry [26].
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DNA from 0.2-0.5 mL BAL was extracted by the auto-
matic MagNa Pure LC DNA-Isolation system (Roche
Diagnostics). Bacteria DNA used for determination of
the analytical sensitivity of the Spn9802 and the P6
PCRs was purified from cultured isolates (S. pneumoniae
CCUG 28588
T and H. influenzae CCUG 23946
T)b y
phenol-chloroform extraction of bacteria harvested in
exponential growth phase after culturing on chocolate
agar at 37°C in 5% carbon dioxide and the concentration
of DNA was determined by a Nanodrop instrument
(NanoDrop Technologies, Inc. Wilmington, DE, USA).
The genome copy number was determined according to
conventional calculations based on molecular weight
and one gene copy per genome.
CSF samples (50 μL-1.5 mL) were centrifuged at
12 000 g for 20 min, after which DNA was extracted
from the pellet with a bacterial DNA preparation kit
(Roche Diagnostics, Indianapolis, USA), used according
to the manufacturer’s instructions.
qmPCR
The quantitative Spn9802 PCR for the detection of
S. pneumoniae [17] was combined with the P6 PCR for
the detection of H. influenzae [21] and the ctrA PCR for
the detection of Neisseria meningitidis [14]. All primers
and probes are shown in Table 1 where positions with
lower case letters indicate locked nucleic acid [27].
The PCR for detection of N. meningitidis was used as
described previously, except that 3.5 mmol/L MgCl2 was
used instead of 5.5 mmol/L and that the elongation
time was 40 s instead of 1 min. All primers and probes
were obtained from Thermo Hybaid, Interactiva Divi-
sion (Ulm, Germany) except the Spn9802 FAM probe
which was obtained from Eurogentec, Seraing, Belgium.
The real-time PCR assay was performed in a Rotor-
Gene 3000 instrument (Qiagen, Hilden, Germany). The
optimized real-time PCR amplifications were per-
formed in 25-μL reactions containing 0.3 μmol/L of
each primer, 0.2 μm o l / Lo ft h eS p n 9 8 0 2F A Mp r o b e ,
0.1μmol/L of the P6 JOE probe and ctrA ROX probe,
3.5 mmol/L MgCl2, 0.2 mmol/L deoxynucleoside tri-
phosphate, and 1 U HotStar Taq polymerase (Qiagen)
in PCR buffer. A total of 5 μLo ft a r g e tD N Aw a su s e d
in the assay. The qmPCR was performed according to
the following program: 15 min of enzyme activation at
95°C, followed by 45 cycles of 95°C for 15 s and 60°C
for 40 s.
Reproducibility of analytical sensitivity and quantification
The analytical sensitivity of the Spn9802, P6 and ctrA
PCRs was determined by serial dilutions of target DNA
in carrier tRNA (1μg/mL). Two experiments were per-
formed with 5 to 600 genome copies per reaction tube
and 2 to 4 tubes of each dilution.
The reproducibility of quantification was evaluated by
testing DNA preparations with known concentrations
(duplicates of 500, 2,000 and 10,000 genome copies per
PCR reaction) in five consecutive runs and also in 73
BAL samples and in 8 CSF samples. PCRs with primer/
probe reagents in both monoplex and multiplex were
tested in parallel. In addition we tested the reproducibil-
ity of quantification with positive control DNA of
S. pneumoniae, H. influenzae and N. meningitidis in
separate tubes and combined in a single tube.
fucK PCR
The fucK PCR was used as previously described [28], to
confirm the presence of H. influenzae in samples which
proved negative by culture but positive by qmPCR.
Table 1 Oligonucleotide primers and probes for detection of S. pneumoniae, H. influenzae and N. meningitidis.
Sequence (5’ to 3’)
a Positions in target gene
S. pneumoniae
Spn9802 F 5’-A GTC GTT CCA AGG TAA CAA GTC T-3’ 3370-3392
Spn9802 R 5’-AC CAA CTC GAC CAC CTC TTT-3’ 3525-3506
Spn9802 FAM 5’-
FAM-aTc AGa TTg CTg ATa AAa CgA-
BHQ1-’3
H. influenzae
Hi P6 F 5’-CCA GCT GCT AAA GTA TTA GTA GAA G-3’ 302-326
Hi P6 R 5’-TTC ACC GTA AGA TAC TGT GCC-3’ 477-457
Hi P6 JOE 5’-
JOE- CAg ATg CAg TTg AAg GTt Att tAG-
BHQ1-’3
N. meningitidis
ctrA F 5’-GCTGCGGTAGGTGGTTCAA-3’ 617-635




a Positions with lower case letters indicate locked nucleic acid [27].
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For respiratory samples the lytA PCR was tested in a gel
based PCR for S. pneumoniae as previously described
[29]. In short, extracted DNA (10 μL) was added to a
PCR mixture, and after 40 cycles, PCR products were
detected on ethidium bromide-stained agarose gels. By
serial dilution of bacterial strains, the detection level of
lytA PCR has been shown to be 10
2 colony forming
units (CFU)/mL sample [29].
16 S rRNA PCR for CSF samples
The primers and other PCR conditions used to amplify the
5’-half of the 16 S rRNA gene were previously described
[24]. The PCR product was visualized in an agarosegel and
DNA bands of expected size were cut from the gel, puri-
fied with a Qiaquick Gel Extraction kit (Qiagen) and sub-
jected to cycle sequencing using the ABI prism Big Dye
Terminator Sequencing Ready Reaction kit, v.1.1 (Applied
Biosystems). The sequencing reaction products were ana-
lyzed using an ABI PRISM 310 Genetic Analyser (Applied
Biosystems). After DNA sequence editing, the GenBank
BLAST program was used for sequence comparisons.
Ethics
The study was performed according to the Declaration
of Helsinki II and approved by the local ethical commit-
tee and all participating patients gave written consent.
Results
A sensitive and specific multiplex PCR for quantitative
detection of S. pneumoniae, H. influenzae and N. menin-
gitidis was developed and evaluated on BAL samples
from adults with LRTI and a control group, and on CSF
samples from patients with meningitis. To establish the
detection capacity of the Spn9802, the P6 and the ctrA
assays, serial dilutions of target DNA with known con-
centration were repeatedly tested and the analytical sen-
sitivity was 10-60 copies per PCR reaction for the
Spn9802 assay, 3-30 copies per PCR reaction for the P6
assay and 5-50 copies per PCR reaction for the ctrA
assay. As shown in Table 2 the analytical sensitivity and
quantification was not affected by using a combined
mixture of reagents and a combined DNA standard
(S .p n e u m o n i a e ,H .i n f l u e n z a eand N. meningitidis)i n
single tubes.
Table 3A shows results of tests for S. pneumoniae and
H. influenzae in the patient group. Of 156 LRTI patients
S. pneumoniae was identified by conventional tests in
21 (13%) cases, and by qmPCR in 54 (35%) cases, includ-
ing 47 cases using a cut-off level of 10
5 copies/mL.
From the 21 patients with conventional (blood culture,
BAL culture, or urinary antigen test) tests positive for S.
pneumoniae, 20 were positive by qmPCR. In addition 34
cases with no conventional test positive for S. pneumo-
niae were positive with Spn9802 PCR of which 26 were
Table 2 Detection capacity of multiplex quantitative PCR

















H. influenzae and N.
meningitidis






Spn 10000 (5) 27.7 27.8 0.1
Spn 2000 (5) 30.2 30.4 0.2
Spn 500 (7) 32.7 32.4 -0.3
Hi 10000 (5) 23.8 23.7 -0.1
Hi 2000 (5) 26.4 26.4 0.0
Hi 500 (7) 28.6 28.5 -0.1
Mc 10000 (4) 27.6 27.4 -0.2
Mc 2000 (4) 30.5 30.0 -0.5
Mc 500 (6) 32.5 32.3 -0.3
Spn (23 clinical samples) 27.7 ± 7.6 3.9 ± 1.8 28.2 ± 7.6 3.8 ± 2.0 0.5 -0.1
Hi (50 clinical samples) 24.1 ±
10.7
3.9 ± 2.8 24.7 ± 7.6 3.8 ± 3.0 0.6 -0.1
Mc (8 clinical samples) 22.0 ± 1.9 5.2 ± 0.5 22.2 ± 2.0 5.2 ± 0.5 0.2 0
Ct = Cycle of threshold; Spn = S. pneumoniae;H i=H. influenzae;M c=N. meningitidis
Comparison of using PCR reaction mix with a single DNA standard and oligos for one target organism versus triplex DNA target standard and oligos for 3 target
organisms.
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mococcal bacteraemia, S. pneumoniae was identified by
BAL culture in one case, by urinary antigen test in one
case, and by qmPCR and lytA PCR in all the 6 patients.
Similarly, among the 9 patients with positive urinary
antigen test, S. pneumoniae was identified in 8 by BAL
qmPCR and in seven by lytA PCR, and none by BAL
culture.
H. influenzae was not found in any blood culture but
was detected by BAL culture in 31 cases, of which 28
also were positive by qmPCR. Of 44 cases proved nega-
tive by culture but positive by qmPCR, 41 were con-
firmed by fucK PCR.
Among the 31 control patients S. pneumoniae and
H. influenzae were identified by BAL culture in 2 (6%)
and 3 (10%) cases respectively, by qmPCR in 8 (26%)
and 11 (35%) cases (Table 3B). Of 7 and 8 cases proved
negative by culture but positive with qmPCR for
S. pneumoniae and H. influenzae respectively, 2 were
positive by lytA PCR for S. pneumoniae and 7 were
positive by fucK PCR for H. influenzae.
Figure 1 shows the qmPCR copy number of the LRTI
patients and controls compared to results by culture,
urinary antigen test and lytA PCR. Among the qmPCR
positive subjects, the LRTI patients and controls had a
similar mean log 10 of copy number 5.69 (standard
deviation [SD] 1.53) versus 5.65 (SD 1.63); p =0 . 7 9 ,f o r
H. influenzae a n d6 . 3 1( S D1 . 1 2 )v e r s u s5 . 9 3( S D0 . 9 6 ) ;
p =0 . 3 6 ,f o rS. pneumoniae). If the cut-off limit for a
positive qmPCR result was risen to 10
5 DNA copies/mL,
the positivity rate among the controls would drop from
26% (8/31) to 16% (5/31) for S. pneumoniae and from
35% (11/31) to 19% (6/31) for H. influenzae. Similarly in











Spn & Hi Spn & Hi 1 1
Spn & Hi Hi 1 1
Spn Spn & Hi 5 4
Spn Spn 14 6
- Spn 20 15
- Spn & Hi 9 7
Hi Spn & Hi 5 5
Hi Hi 21 12
Hi - 3 3
-H i 3 0 2 6




Hi Spn & Hi 1
Hi Hi 2 1
- Spn 3 1
- Spn & Hi 3
-H i 4
- - 16 1
a Blood culture, urinary antigen test, and BAL culture for S. pneumoniae; blood
culture and BAL culture for H. influenzae.; -, negative test result.
b Spn9802+ was considered as S. pneumoniae+; P6+ was considered as
H. influenzae+.
Results of reference tests and qmPCR for Streptococcus pneumoniae (Spn) and
Haemophilus influenzae (Hi) applied to bronchoalveolar lavage (BAL) samples
in 156 patients with lower respiratory tract infection (A) and in 31 control
patients (B).
Figure 1 Multiplex real-time PCR copy numbers of target organisms in patients and controls.C o m p a r i s o no fP C Rc o p yn u m b e r si nt h e
LRTI patients and controls compared with culture, urinary antigen test and gel-based lytA PCR.
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35% (54/156) to 30% (47/156) for S. pneumoniae and
from 46% (72/156) to 20% (31/156) for H. influenzae.
Table 4 shows the sensitivities and specificities of the
qmPCR, with the detection limit of the PCR assay itself
and a detection limit of 10
5 copies/mL. Since one urin-
ary antigen test positive patient had Spn9802 DNA
determined at <10
5 copies/mL and three culture positive
patients had P6 DNA determined at <10
5 copies/mL,
the raise of the cut-off limit to 10
5 copies/mL, would
drop the sensitivities, but the specificities would
increase.
Among 103 patients treated with antibiotic before
sampling, S. pneumoniae and H. influenzae were identi-
fied by culture in 6% (6/103) and 20% (21/103) respec-
tively, and by qmPCR in 36% (37/103) and 53% (55/103)
respectively. Of 22 patients positive by Spn9802 PCR
and lytA PCR alone 19 of them had antibiotics prior to
sampling.
Figure 2 shows the quantitative results of the qmPCR
compared to semi-quantitative culture of BAL speci-
mens for S. pneumoniae and H. influenzae.T h e r ew a s
no correlation between the measured DNA copy num-
ber/mL and the bacterial growth.
Table 4 Sensitivities and specificities of multiplex real-time PCR for detection of S. pneumoniae and H. influenzae.




b Sensitivity Specificity PPV NPV


















BAL culture, blood culture and urinary




















































a Positive predictive value
b Negative predictive value
c Blood culture were also performed for H. influenzae but all were negative
d fucK PCR was performed in the PCR positive and culture negative samples
Analysis of bronchoalveolar lavage from 156 adults with lower respiratory tract infection.
Figure 2 Quantitative results of the multiplex real-time PCR compared to semi-quantitative culture of BAL specimens.
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N. meningitidis in patients with meningitis. Of 87 CSF
samples, S. pneumoniae and N. meningitidis were
detected by culture in 5 (6%) and 2 (2%) samples, by 16
Sr R N APCR in 14 (16%) and 10 (11%) and by qmPCR
and in 14 (16%) and 10 (11%) samples respectively.
Altogether, culture, 16 S rRNA PCR and qmPCR were
positive for S. pneumoniae in 14 cases, N. meningitidis
in 10 cases, and H. influenzae in no case. If culture and
the 16 S rRNA PCR in combination were used as refer-
ence standard for aetiology of meningitis, the sensitiv-
ities and specificities would be 100% and 100% for both
S. pneumoniae and N. meningitidis. Two samples posi-
tive by the ctrA PCR were positive in the unspecific 16
Sr R N APCR and sequence analysis of the PCR product
determined them as Neisseria spp. They were consid-
ered as N. meningitidis in the specificity calculation. Of
17 samples that were negative by culture but positive by
qmPCR 8 samples originated from patients that were
under antibiotic treatment (Amoxyclav PO, Cefotaxime
IV or Cefuroxime IV) before lumbar puncture.
Discussion
In this study we established a sensitive detection system
that enabled simultaneous quantification of S. pneumo-
n i a e ,H .i n f l u e n z a eand N. meningitidis DNA using
qmPCR. The multiplex assay was reproducible and no
change in detection and quantification capacity was seen
when a combined mixture of reagents and a combined
DNA standard (S. pneumoniae/H. influenzae/N. menin-
gitidis)i ns i n g l et u b e sw a su s e d( T a b l e2 ) .T h i sm u l t i -
plex PCR assay reduced the expense of reagents and the
required time for analysis.
Antibiotic treatment prior sampling has been found to
reduce the positivity rate of BAL culture from 92% to
55% in patients with severe community acquired pneu-
monia [6]. In this study 66% (103/156) of the patients
had antibiotic therapy prior the sampling, this high rate
of antibiotic treatment is probably the reason for the
suboptimal specificity of the qmPCR. Of 78 samples
which were negative by culture and positive for S. pneu-
moniae or H. influenzae by the qmPCR, 64 were treated
with antibiotic 0-7 days prior to sampling. The high rate
of prior antibiotic treatment was probably also the
reason for the lack of correlation between DNA concen-
tration and bacterial concentration determined by semi-
quantitative culture (Figure 2). This lack of correlation
between quantification of target DNA and culture con-
trasts to our previous analysis of nasopharyngeal aspi-
rates from community acquired pneumonia patients,
where a significant correlation was seen, but only 25%
of patients were on antibiotic treatment when samples
were collected in the previous study [17,21].
The evaluation of nucleic acid amplification tests by
comparison with less sensitive reference methods such
as culture is problematic. Several imperfect tests may be
used to define a composite reference standard [30]. An
alternative way to resolve cases with different test results
is to use discrepant analysis where an additional method
is used to determine the specimen status. Such analyses
have been criticized [31], but is often the most realistic
procedure for the evaluation of new methods that are
more sensitive than an established reference method. In
our study the Spn9802 target was evaluated by a compo-
site reference standard and for the P6 target discrepant
analysis was used. This resulted in increased specificity
and a higher number of pneumonia cases with defined
etiology. As expected the positive predictive values
increase with increased specificity, thus with a cut-off
limit of 10
5 copies/mL a positive PCR result is very reli-
able using an extended reference standard.
We have recently shown that Spn9802 PCR and P6
PCR are specific for S. pneumoniae and H. influenzae
when bacterial strains have been tested.
Nevertheless, colonization of S. pneumoniae and H.
influenzae in the respiratory tract is problematic for
both culture and PCR. To overcome this problem semi-
quantitative culture is often used. In our study a detec-
tion limit of 10
5 DNA copies/mL for positive Spn9802
and P6 PCRs yielded a high specificity but somewhat















S. pneumoniae ++ + 5 2
-+ + 9 5




b -- - 6 3
a Neisseria spp DNA was detected by 16 S rRNA PCR in 2 samples and sequence determined as Neisseria spp. Here considered as N. meningitidis
b Negative for N. meningitidis and H. influenzae
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previous studies [6,32,33] based on BAL culture and
demonstrated that a cut-off of 10
4-10
5 CFU/mL allow
differentiation between colonization and infection of the
lower respiratory tract. However, CFU/mL does not
automatically correspond to the number of DNA
copies/mL since several bacteria may aggregate and gen-
erate one colony although they constitute several gen-
ome equivalents. Furthermore, as described above
antibiotic treatment before sampling and smoking habits
have an effect on the number of detected bacteria. Thus
patient treatment and the patient group characteristics
affect the possibility of using quantification to differenti-
ate between colonization and infection.
When the multiplex PCR was applied on CSF samples,
our assay was able to detect all the cases of N. meningi-
tidis and S. pneumoniae that were found by culture and/
or 16 S PCR in a previous study [24]. The problem of
choosing optimal targets for S. pneumonia and H. influ-
enzae has been addressed above. The primer pair used
for N. meningitidis in our assay has previously been
used in a multiplex assay for detection of bacterial
meningitis [14] and even been evaluated in a major
interlaboratory comparison of PCR-based identification
of meningococci [34] as well as in other studies with
satisfying results [35,36].
Conclusions
Although culture is still indispensable in bacteriological
diagnostics multiplex PCR enables concurrent diagnos-
tics of viruses and fungi and provides a powerful tool
for analysis. We conclude that the multiplex format of
the assay facilitates diagnostics of S. pneumoniae,
H. influenzae and N. meningitidis and is suitable for
analysis of both respiratory tract tract and CSF speci-
mens. The assay also enable detection after antibiotic
treatment has been installed. Quantification increases
the specificity of etiology for pneumonia.
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